Return-path: Envelope-to: sales_marketing@ferozsons-labs.com Delivery-date: Tue, 24 Jun 2014 12:45:58 -0700 Received: from nm45-vm3.bullet.mail.bf1.yahoo.com ([216.109.115.62]:47537) by advanced644.inmotionhosting.com with esmtps (TLSv1:DHE-RSA-AES256-SHA:256) (Exim 4.82) (envelope-from ) id 1WzWeC-000868-Df for sales_marketing@ferozsons-labs.com; Tue, 24 Jun 2014 12:44:52 -0700 Received: from [66.196.81.172] by nm45.bullet.mail.bf1.yahoo.com with NNFMP; 24 Jun 2014 19:44:51 -0000 Received: from [98.139.212.243] by tm18.bullet.mail.bf1.yahoo.com with NNFMP; 24 Jun 2014 19:44:51 -0000 Received: from [127.0.0.1] by omp1052.mail.bf1.yahoo.com with NNFMP; 24 Jun 2014 19:44:51 -0000 X-Yahoo-Newman-Property: ymail-3 X-Yahoo-Newman-Id: 344071.85607.bm@omp1052.mail.bf1.yahoo.com Received: (qmail 69763 invoked by uid 60001); 24 Jun 2014 19:44:51 -0000 DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=yahoo.com; s=s1024; t=1403639091; bh=gyvNavCO1tm5ESBF8H5tcx8/mLqLoeum8sUk9d6Cjsk=; h=References:Message-ID:Date:From:Reply-To:Subject:To:In-Reply-To:MIME-Version:Content-Type; b=NGCyit/UMOWrfJ8cxHHGnl/lYTQKR8wReLUYPvcpvk/CcjDAZ45Qm6ueKeyM2RWtoWRvOTeLgBjZiqkOl0FMOGygKHn6cMxPoRfI4kSl+nrlrVyMz131fBHOc6NDJtT439cHsyAiqxK7bupy6LLIWjBhMeMfb0IbBhsKZp5ut8Y= X-YMail-OSG: c.cmqNoVM1lr7NlDtu8vGi7u3LOEDByTP2kAWp5NdgomepZ bqTQEl8V7OpS8UWCUOsus.1gSZ3rAcbCf1AjOp6OSxX5s4fCo0V3dPts.grd P9bq5extIOX2e1VuDCeUHrPdLtxXihxrxea5N8WjpaCdb5pUNh706Od0ugyC uBRUsOpbdkRFyUB20SrTb..EDCUsyOqUnKSuV8kQyWuQfNZ5hQOCKDI4njYM nctGuNWWVb6pHr7PjR2LILqFNyAu8nUCFTIJexwahii4AUAAEnzyKSmpHd.X qErCtMJsvWsfuBCkIqi_E7NIblWVXU.W6CoOGFA5IPwo7i3g3lxUtK4phPvA 5zzNLe42BdbT.iJhnK9Vgl4IbbiAEl.fN5dx6WQUn5HwJ0.qYVrywXEpVfUS SFNk0cZrvrD19byxeNOiYt0nkkxl0_EYo4NG3oHqtMVGdNEGZrre2vZPHtho tC30FEGA5EkPdtG04wUGbLWCPSKKqIIklojYlwH_Vuv0pCWcFdn9vHifb.5q hXe1yw243j6Z447jSMSptlPDT.oNVFbDSq44fDjJv5JUMewA0agqd746yBES AwstFKz.60bKSL9wfho931XrlMoiuQvqhdSnroDXoky1WXk9BHCvUGZwcytN 9X9ysLNFCMgM068CV4rxCLVzP5quue10ce98DYkj0oRCOXaWgFuWOqCbH1WH 8TJGgMFOimUd6irf75VW_v7nGlApW92pNk1ZM6JTyyBaM8w1pS78h2Pkn4yz slm.0fkKCIvM4TMcggx4jxvAJPyjIJnd2GP0n7K5zqHpf.JoeIZn7nW.34.e 61X2EoSM9ecmAxYijvfVxDEi0cZKBszOiXCJx Received: from [39.48.20.155] by web162504.mail.bf1.yahoo.com via HTTP; Tue, 24 Jun 2014 12:44:51 PDT X-Rocket-MIMEInfo: 002.001,R3JlYXQuLi4KR28uLiBHcm93Li4uIGFuZCBHbG93Li4uRmVyb3pzb25zISEhCgpSZWdhcmRzLgoKQXNhZCBLaGFuCkhNIEtoaS4KCgoKCl9fX19fX19fX19fX19fX19fX19fX19fX19fX19fX19fCiBGcm9tOiBEci4gU29oYWlsIE1hbnpvb3IgPHNvaGFpbG1hbnpvb3JAeWFob28uY29tPgpUbzogc2FsZXNfbWFya2V0aW5nQGZlcm96c29ucy1sYWJzLmNvbSAKU2VudDogVHVlc2RheSwgMjQgSnVuZSAyMDE0LCAxMjoyNgpTdWJqZWN0OiBGZXJvenNvbnMgbGJzLiBzaWducyBhZ3JlZW1lbnQgd2l0aCBHaWxlYWQBMAEBAQE- X-Mailer: YahooMailWebService/0.8.191.1 References: <48355B17-F5F9-42F6-8370-1CCD7CD2BA38@yahoo.com> Message-ID: <1403639091.71500.YahooMailNeo@web162504.mail.bf1.yahoo.com> Date: Tue, 24 Jun 2014 12:44:51 -0700 From: asaDKhan Reply-To: asaDKhan Subject: Re: Ferozsons lbs. signs agreement with Gilead sciences .... aap sab ku mubarik hu To: "Dr. Sohail Manzoor" , "sales_marketing@ferozsons-labs.com" In-Reply-To: <48355B17-F5F9-42F6-8370-1CCD7CD2BA38@yahoo.com> MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="275539708-1017963675-1403639091=:71500" --275539708-1017963675-1403639091=:71500 Content-Type: text/plain; charset=utf-8 Content-Transfer-Encoding: quoted-printable Great...=0AGo.. Grow... and Glow...Ferozsons!!!=0A=0ARegards.=0A=0AAsad Kha= n=0AHM Khi.=0A=0A=0A=0A=0A________________________________=0A From: Dr. Soh= ail Manzoor =0ATo: sales_marketing@ferozsons-labs.= com =0ASent: Tuesday, 24 June 2014, 12:26=0ASubject: Ferozsons lbs. signs a= greement with Gilead sciences .... aap sab ku mubarik hu =0A =0A=0AFerozson= s Lab, Gilead Sciences sign agreement - thenews.com.pk =0A =0A =0A=C2=A0Tue= , Jun 24, 2014, Shaban 25,1435 A.H : Last updated 1 hour ago =0A=C2=A0=0A= =C2=A0=0AToday's Paper | Archive | e-Paper =0AGroup Chairman: Mir Javed Rah= man =0A =0AFounded by: Mir Khalil-ur-Rahman =0A=0A=0AEditor-in-Chief: Mir = Shakil-ur-Rahman =0A=09* Latest News> =0A=09* Pakistan =0A=09* National=0A= =09* Islamabad=0A=09* Karachi=0A=09* Lahore=0A=09* Peshawar=0A=09* Quetta= =0A=09* Other Cities=0A=09* World =0A=09* Sports=0A=09* Business =0A=09* Fo= rex=0A=09* Bullion Rates=0A=09* KSE Quotes=0A=09* Weird=0A=09* Entertainmen= t=0A=09* Health=0A=09* Sci-Tech=0A=09* Opinion =0A=09* Editorial=0A=09* Op= inion=0A=09* Newspost=0A=0A=09* Today's Paper =0A=09* Top Story=0A=09* Ele= ction 2013 - SP Report=0A=09* National=0A=09* World=0A=09* Business=0A=09* = Sports =0A=09* Islamabad=0A=09* Karachi=0A=09* Lahore=0A=09* Peshawar=0A=09= * Aman Ki Asha=0A=09* Instep Today=0A=09* Blog =0A=09* The News On Sunday= =0A=09* Money Matters =0A=09* You=0A=09* Us =0A=09* Photos=0A=09* Videos= =0A=09* Cartoons=0A=09* Results=0A=09* Archive =0A=09* Back Issues=0A=09* O= pinion Archive=0A=09* Writers Archive=0A=0AHot Topics =C2=A0 =C2=A0NWA Oper= ation=C2=A0 =C2=A0Musharraf=C2=A0 =C2=A0Federal Budget 2014-15=C2=A0 =C2= =A0Altaf Hussain =C2=A0 =C2=A0Hamid Mir=C2=A0 =0AJang/Geo Response to Al= legations=C2=A0 =0A=C2=A0You are here: Home > Today's Paper > Business = =0A =0A=C2=A0=0A =0A=C2=A0=0A=C2=A0Business =0A=C2=A0=0AFerozsons Lab, Gil= ead Sciences sign agreement =0A=C2=A0=0A=C2=A0=0AJaved Mirza=0A Friday, Jun= e 20, 2014 =0AFrom Print Edition =0A=C2=A0=0A=C2=A0=0A=C2=A029 =C2=A00 =C2= =A02 =C2=A01 =0A=0A=C2=A0 =0AKARACHI: Ferozsons Laboratories Limited has en= tered into an agreement with Gilead Sciences to be its exclusive branded me= dicines business partner for Pakistan, officials said on Thursday.=0A=C2=A0= =0AUnder the agreement, Ferozsons will market and distribute certain Gilead= medications for the treatment of chronic Hepatitis-C; HIV and chronic Hepa= titis-B virus (HBV) infection in Pakistan, the officials said.=0A=C2=A0=0AO= sman Khalid Waheed, president of Ferozsons Laboratories Limited, said: =E2= =80=9CThe agreement is a very important milestone for the company but more = significantly it also marks a paradigm shift in the treatment landscape for= diseases such as Hepatitis C, which affects over 10 million people in the = country. We look forward to bringing these new innovations to patients in P= akistan.=E2=80=9D=0A=C2=A0=0AStribild and Sovaldi are pending registration = in Pakistan. The registration application for Sovaldi was submitted in May = with the request for an accelerated review on the basis of medical needs, h= e said.=0A=C2=A0=0AIn addition to distributing branded Gilead medicines, Fe= rozsons will manage regulatory and pharmaco-vigilance activities such as ad= verse event reporting, as well as broader medical education initiatives, he= said.=0A=C2=A0=0ASovaldi was approved in the United States on December 8, = 2013 and in the European Union on January 17. In the United States, Sovaldi= is approved for the treatment of chronic Hepatitis-C infection as a compon= ent of a combination antiviral treatment regimen.=0A=C2=A0=0AStribild is a = complete once-daily single tablet regimen for the treatment of HIV-1 infect= ion.=0A=C2=A0=0ATruvada is a fixed-dose once-daily combination pill contain= ing Viread and Emtriva. It is used in combination with other antiretroviral= agents for the treatment of HIV infection in adults and pediatric patients= 12 years of age and older, he said.=0A=C2=A0=0AViread is a once-daily oral= nucleotide reverse transcriptase inhibitor (NtRTI) for the treatment of HI= V infection in patients two years of age and older in combination with othe= r antiretroviral agents. =0A=C2=A0=0AViread is also approved as a treatment= for chronic Hepatitis-B in adults and pediatric patients 12 years of age a= nd older. Viread is also indicated for the treatment of chronic Hepatitis-B= virus (HBV) infection in adults.=0A=C2=A0=0AGilead Sciences is an American= biotechnology company that discovers, develops and commercialises therapeu= tics. For many years since the company was founded, the company concentrate= d primarily on antiviral drugs to treat patients infected with HIV, Hepatit= is-B, or influenza.=0A=C2=A0=0AFerozsons is the Pakistan=E2=80=99s marketin= g and distribution partner for the Boston Scientific Corporation, US for it= s range of cardiac and peripheral products and interventional devices.=0A= =C2=A0=0A=C2=A0=0AToday's Newspaper =0ATop story National =0AWorld Bus= iness =0ASports Karachi =0ALahore Islamabad =0APeshawar Editorial = =0AOpinion Newspost =0A=C2=A0=0A=C2=A0=0A=C2=A0=0A=C2=A0=0A=C2=A0=0AMore= from Business =0A=C2=A0=0A=C2=A0=E2=80=98Private chartered flights can ear= n up to $500m per annum=E2=80=99 =C2=A0Foreigners encouraging local invest= ment =0A=C2=A0Nepra grants upfront tariff for wind projects =C2=A0Ten com= panies participate in SAITEX, AB7 =0A=C2=A0KSE MD, DMD appeal against SECP= penalty =C2=A0Car industry struggles to solve air bag explosions despite = mass recalls =0A=C2=A0=E2=80=98IROs must be promoted to BPS-17=E2=80=99 = =C2=A0French politics trump business over Alstom =0A=C2=A0IGI, Packages Gr= oup join hands =C2=A0Intel holds workshop =0A=C2=A0=0A=C2=A0=0A=C2=A0=0A= =C2=A0=0A=C2=A0 =0A=C2=A0=0A=C2=A0=0A=C2=A0=0ALatest News =0ASanaullah admi= ts mismanagement caused Model Town tragedy =0AKhyber Agency: Jet fighter = air strike kills 6 of the same family =0AMore than 350 PAT workers booked= =0ALahore incident: Sana, Shah didn=E2=80=99t appear before tribunal = =0ASC overrules SHC order, Musharraf to stay on ECL =0AAfghan allegations= termed baseless by Pakistan =0A4 matches to be played today =0AFour-st= ar Prasad stuns England in second Test =0AMessi turns 27 today =0ALast = dangerous chemicals shipped from Syria: watchdog =0A=C2=A0=0A=C2=A0=0A=C2= =A0=0A=C2=A0=0A=09* Pakistan =0A=09* World =0A=09* Sports =0A=09* Business = =0A=09* Weird =0A=09* Technology =0A=09* Entertainment =0A=09* Video Galler= y =0A=09* Magazines =0A=09* Facebook =0A=09* Blog =0A=09* Twitter =0A=09* G= oogle Plus =0A=09* Photo Gallery =0A=09* My City =0A=09* Islamabad =0A=09* = Karachi =0A=09* Lahore =0A=09* Peshawar =0A=09* Quetta =0A=09* Other Cities= =0A=09* Print Edition =0A=09* Editorial =0A=09* Opinion =0A=09* Newspost = =0A=09* Sports =0A=09* National =0A=09* Writers Archive =0A=09* Contact Us = =0A=09* Classified =0A=09* Viewers' Forum =0A=09* How to Advertise =0A=09* = Opinion Archive =0A=09* About Us =0A=09* Feedback =0A=09* RSS =0A=09* Video= s =0A=09* E-Paper =0A=09* Mobile =0A=09* Back Issues =0A=09* =C2=A0 =0A=09*= Sitemap =0AThe News International - Copyright @ 2010-2012 =0A=0AThird-part= y Advertisement Policy |Privacy Policy | Contact Us =0ALoading... --275539708-1017963675-1403639091=:71500 Content-Type: text/html; charset=utf-8 Content-Transfer-Encoding: quoted-printable
Great...=
Go.. Grow... and Glow...Ferozsons!!!

Regards.
Asad Khan
HM K= hi.



From: Dr. Sohail Manzoor <sohailmanzoor@yahoo.com>
To: sales_marketing@ferozsons-l= abs.com
Sent: Tuesday, 24 June 2014, 12:26
Subject: = Ferozsons lbs. signs agreement with Gilead sciences .... aap sab ku mubarik= hu
<= div class=3D"yiv8046381749" style=3D"">
=0A=09Ferozsons Lab, Gil= ead Sciences sign agreement - thenews.com.pk=0A<= style type=3D"text/css">#yiv8046381749 .yiv8046381749highslide img {cursor= :pointer;}
=0A=0A=0A =0A = =0A=0A=0A =0A = =0A =0A=0A=0A =0A=0A =0A=0A=0A=0A =0A=0A=0A
= =0A
=0A=0A
=0A=0A
=0A
=0A=0A
=0A
=0A Tue, Jun 24= , 2014, Shaban 25,1435 A.H=0A : Last updated 1 hour = ago=0A
=0A
=0A
=0A =0A
=0A
=0A =0A3D"The=0A=0A
=0A
=0A
 
=0A=0A=0A
 
=0A=0A=0A
=0A=0A
=0A
=0A
=0AToday's Paper=0A|=0A<= a rel=3D"nofollow" shape=3D"rect" class=3D"yiv8046381749" id=3D"yiv80463817= 49ctl00_HyperLinkBackIssues" title=3D"Archive" style=3D"" href=3D"">Archive= =0A|=0Ae-Paper=0A
= =0A =0A
=0AGroup Chairman: Mir Javed Rahman=0A
=0A = =0A
=0A =0A
=0A 3D"thenews.com.pk"=0A
= =0A Founded by: Mir Khalil-ur-Rahman =0A
=0A=0A=0A
=0A=0A
=0A
= =0A=0A
= =0A Editor-in-Chief= : Mir Shakil-ur-Rahman=0A
=0A=0A =0A
= =0A=0A
=0A
=0A
=0A= =0A=0A=0A=0A =0A=0A=0A=0A=0A=0A=0A=0A=0A=0A =0A =0A =0A =0A=0A=0A =0A=0A= =0A=0A=0A=0A=0A=0A=0A=0A
=0A=0A
= =0A=0AHot Topics=0A =0A=0A  NWA Operation =0A = 3D""=0A=0A  Musharraf&nb= sp;=0A 3D""=0A=0A =  Federal Budget 2014-15 =0A 3D""=0A=0A  Altaf Hussain  =0A = 3D""=0A=0A  Hamid Mir&n= bsp;=0A 3D""=0A =0A=0A=0A=0A
=0A=0A
=0A=0A =0A =0A Jang= /Geo Response to Allegations =0A =0A =0A =0A=0A
=0A
=0A
= =0A=0A
 
=0A=0A=0A=0A
=0AYou are here: = Home > Today's Paper &= gt; Business=0A
=0A
=0A=0A =0A
=0A=0A =0A=0A = =0A=0A =0A=0A=0A=0A
=0A=0A =0A =0A
=0A =0A
=0A=0A
=0A
=0A =0A
=0A=0A
 
=0A=0A
=0A =0A
=0A=0A
=0A =0A=0A =0A
=0A=0A=0A
=0A =0A
=0A=0A
=0A=0A
 
= =0A=0A=0A
=0A Business= =0A
=0A=0A
 
=0A=0A<= div class=3D"yiv8046381749" style=3D"">=0A=0A=0A
=0A Ferozsons Lab, Gilead Sciences sign agreemen= t=0A
=0A=0A=0A=0A
 =0A
 
=0A=0A
=0A=0AJaved Mirza
=0AFriday, June 20, 2014=0A
=0AFrom Print Edition=0A
=0A=0A
 
=0A
 
= =0A=0A
=0A <= /span>= 29=0A 0=0A 2=0A 1=0A
=0A
=0A=0A=0A
=0A=0A
 
= =0A=
KARACHI: Ferozsons Laboratories Limited has entered into an agree= ment with Gilead Sciences to be its exclusive branded medicines business pa= rtner for Pakistan, officials said on Thursday.
 
Under the agreement, Ferozsons wil= l market and distribute certain Gilead medications for the treatment of chr= onic Hepatitis-C; HIV and chronic Hepatitis-B virus (HBV) infection in Paki= stan, the officials said.
&nbs= p;
Osman Khalid Waheed, presid= ent of Ferozsons Laboratories Limited, said: =E2=80=9CThe agreement is a ve= ry important milestone for the company but more significantly it also marks a paradigm shift in the treatment lan= dscape for diseases such as Hepatitis C, which affects over 10 million peop= le in the country. We look=0A forward to bringing these new innovations to = patients in Pakistan.=E2=80=9D
 
Stribild and Sovaldi a= re pending registration in Pakistan. The registration application for Soval= di was submitted in May with the request for an accelerated review on the b= asis of medical needs, he said.
 
In addition to distri= buting branded Gilead medicines, Ferozsons will manage regulatory and pharm= aco-vigilance activities such as adverse event reporting, as well as broade= r medical education initiatives, he said.
 
Sovaldi was= approved in the United States on December 8, 2013 and in the European Unio= n on January 17. In the United States, Sovaldi is approved for the treatmen= t of chronic Hepatitis-C infection as a component of a combination antiviral treatment regimen.
 
Stribild = is a complete once-daily single tablet regimen for the treatment of HIV-1 i= nfection.
 
Truvada is a fixed-dose once-daily combinat= ion pill containing Viread and Emtriva. It is used in combination with othe= r antiretroviral agents for the treatment of HIV infection in adults and pe= diatric patients 12 years of age and older, he said.
 
= Viread is a once-daily oral nucleotide reverse transcriptase inhibitor (NtR= TI) for the treatment of HIV infection in patients two years of age and old= er in combination with other antiretroviral agents.
 
= Viread is also approved as a treatment for chronic Hepatitis-B in adults and pediatric patients 12= years of age and older. Viread is also indicated for the treatment of chro= nic Hepatitis-B=0A virus (HBV) infection in adults.
 
G= ilead Sciences is an American biotechnology company that discovers, develop= s and commercialises therapeutics. For many years since the company was fou= nded, the company concentrated primarily on antiviral drugs to treat patien= ts infected with HIV, Hepatitis-B, or influenza.
 
Fero= zsons is the Pakistan=E2=80=99s marketing and distribution partner for the = Boston Scientific Corporation, US for its range of cardiac and peripheral p= roducts and interventional devices.
 
=0A
=0A=0A
 
=0A=0A
=0A=0A
= =0A=0A
=0A=0A =
Today's =0A Newspaper
Top story =0A =0A National =0A
World =0A = =0A Business =0A
Sports =0A = =0A Karachi =0A =
Lahore = =0A =0A Islamabad =0A =
P= eshawar =0A =0A Editorial<= /a> =0A
Opinion =0A =0A Newspost =0A
=0A=0A=0A =0A=
=0A=0A=0A
=0A=0A
=0A=0A
 
=0A=0A
  =0A=0A
=0A
=0A =0A
=0A
=0A=0A
=0A=0A
 
=0A=0A
 
=0A=0A
 =0A
=0A=0AMore from Business=0A
 
=0A<= td colspan=3D"1" rowspan=3D"1" class=3D"yiv8046381749" style=3D"">=0A=0A =E2=80=98Private= chartered flights can earn up to $500m per annum=E2=80=99=0A=0A=0A <= /td>
=0A= =0A Foreigners encouraging local investment=0A=0A=0A
=0A=0A Nepra grants upf= ront tariff for wind projects=0A=0A=0A =0A=0A Ten companies pa= rticipate in SAITEX, AB7=0A=0A=0A
=0A=0A KSE MD, DMD appeal against SECP penalty=0A=0A=0A = = =0A=0A&n= bsp;Car industry struggles to solve air bag explosions despite mass recalls= =0A=0A=0A
=0A=0A = =E2=80=98IROs must be promoted to BPS-17=E2=80=99=0A=0A=0A =0A=0A French politics trump business over Alstom=0A=0A=0A
=0A=0A IGI, Packages Group join hands=0A=0A=0A = =0A= =0A Intel holds workshop=0A= =0A=0A
=0A=0A=0A=0A
 
=0A
=0A=0A
 
=0A=0A
=0A
=0A =0A
=0A
 
=0A
=0A=0A=0A
 
=0A
  =0A=0A=0A
=0A
=0A =0A=0A
=0A=0A=0A
 
=0A
 
=0A=0A
=0A=0A=0A=0A
=0A
=0A =0A
=0A
 
=0A=0A
=0A=0A
=0A
=0A = Latest News=0A
=0A =0A
= =0A =0A =0A=0A
=0A =0ASanaullah admits mismanagement caused Model Town tragedy=0A=0A=0A
=0A = =0A =0A =0A
= =0A =0A =0A=0A
=0A =0AKhyber Agency: Jet fighter air strike kills 6 of the same family<= /a>=0A=0A= =0A
=0A =0A =0A =0A
=0A =0A =0A=0A
= =0A =0AMore tha= n 350 PAT workers booked=0A=0A=0A
=0A =0A =0A =0A <= /td>
=0A =0A =0A=0A
=0A =0ALahore incident: Sana, Shah didn= =E2=80=99t appear before tribunal=0A=0A=0A
=0A =0A =0A = =0A
=0A =0A =0A=0A =0A =0A =0A =0A
=0A =0A =0A=0A
=0A =0AAfghan allegations termed baseless by Pakistan=0A=0A=0A =0A =0A =0A =0A
=0A =0A =0A=0A
=0A =0A4 matches to be played= today=0A<= img class=3D"yiv8046381749" title=3D"Watch Now" style=3D"border-width:0px;"= >=0A=0A
=0A =0A =0A =0A
=0A =0A =0A=0A
=0A =0AFour-star Prasad stuns England in second Test=0A=0A=0A
=0A = =0A =0A =0A
= =0A =0A =0A=0A
=0A =0AMessi turns 27 today=0A=0A=0A
= =0A =0A =0A =0A
=0A =0A =0A=0A
=0A =0ALast dangerous chemicals shipped from Syria: watchdog=0A=0A=0A
=0A = =0A =0A =0A
=0A
=0A=0A=0A =0A =0A=0A
 
=0A= =0A
=0A
=0A =0A
=0A
=0A=0A=0A =0A
=0A=0A=0A
=0A=0A=0A
 
=0A=0A
 
=0A=0A=0A =0A=0A=0A=0A =0A=0A
=0A = =0A=0A=0A
 
=0A = =0A =0A
=0A
=0A
=0A=0A=0A
= =0A =0A
=0A=0A =0A
=0A=0A=0A=0A=0A=0A
=0A=0A=0A
=0A
=0A=0A
=0A
=0A=0A
=0A
=0A
=0A=0A=0A
=0A The News International - Copyright @ 201= 0-2012=0A
=0A=0A
=0A=0A=0A=0A=0A=0A =0A
=0A=0A =0A=0A =0A =0A=0A


--275539708-1017963675-1403639091=:71500--